Last week,Ā EBRP CEO, Michael Hund was invited to speak at the
@milkeninstitute Global Conference, one of the most influential cross-sector convenings in the world, where capital, policy, science, and culture meet.Ā Innovative global leaders across finance, health, philanthropy, government, and entertainment gather to drive global impact and action. EBRP was proud to join other innovators like Dr.
@drbiden ,
@pitbull ,
@evalongoria ,
@tiffanyhaddish ,
@tombrady ,
@lionelrichie ,
@shaq , FDA Commissioner
@drmakaryfda , and other world-changing global leaders.
MichaelĀ was invited to join āRewriting the Rules: Scaling Innovation for Rare Diseases,ā a panel that brought together some of the mostĀ influentialĀ voices in rare disease today,Ā or as Michael said, āThe Rare Disease Avengersā.Ā Moderated by Becky Quick of
@cnbc and
@cnbccures , who shared her own journey as the mother of a child with SYNGAP disorder, the panel featured
@dfajgenbaum of
@everycure ,
@nicola_blackwood of
@genomicsengland , Neil Kumar of
@bridgebiopharma , and Will Lewis of Insmed.
Michael shared our Venture into Cureās model, combining data platform innovation and investments in AI, collaborative research/ medical/ industry networks, and venture philanthropy deal structures that return capital to fuel the next breakthrough. An unprecedented model that has now helped accelerate three FDA approvals in two years. That model was built for exactly the kind of cross-sector stage that Milken represents.Ā For the millions living with rare diseases that have never had a treatment, this is not incremental progress. It is a fundamental rewriting of the rules. And it is scalable.
For EBRP, being in that room is not just an honor. It is an affirmation that our approach belongs in the conversation about how the world solves rare disease. Patient-led. Capital-efficient. Scientifically rigorous. We are grateful to the Milken Institute and FasterCures for the platform, and to every patient, family, researcher, and partner whose trust makes this work possible.
š¦ The rules are being rewritten. We intend to helpĀ continue toĀ write them.
š„ Watch the full panel in our bio.